Abstract:ABSTRACT Despite effective antiretroviral therapy reducing HIV-1 viral loads to undetectable levels, the presence of latently infected CD4 + T cells poses a major barrier to HIV-1 cure. N 6 -methyladenosine (m 6 A) modification of viral and cellular RNA has a functional role in regulating HIV-1 infection. m 6 A modification of HIV-1 RNA can affect its stability, translation, and splicing in cells and suppresses type-I interferon induction in macrophages. However, the function of m 6 A modification in regulating HIV-1 latency reactivation remains unknown. We used the Jurkat T cell line-derived HIV-1 latency model (J-Lat cells) to investigate changes in m 6 A levels of cellular RNA in response to latency reversal. We observed a significant increase in m 6 A levels of total cellular RNA upon reactivation of latent HIV-1 in J-Lat cells. This increase in m 6 A levels was transient and returned to steady-state levels despite continued high levels of viral gene expression in reactivated cells compared to control cells. Upregulation of m 6 A levels occurred without significant changes in the protein expression of m 6 A writers or erasers that add or remove m 6 A, respectively. Knockdown of m 6 A writers in J-Lat cells significantly reduced HIV-1 reactivation. Treatment with an m 6 A writer inhibitor reduced cellular RNA m 6 A levels, along with a reduction in HIV-1 reactivation. Furthermore, using m 6 A-specific sequencing, we identified cellular RNAs that are differentially m 6 A-modified during HIV-1 reactivation in J-Lat cells. Knockdown of identified m 6 A-modified RNA validates these results with an established primary CD4 + T cell model of HIV-1 latency. These results show the importance of m 6 A RNA modification in HIV-1 latency reversal. IMPORTANCE RNA m 6 A modification is important for regulating gene expression and innate immune responses to HIV-1 infection. However, the functional significance of m 6 A modification during HIV-1 latency reactivation is unknown. To address this important question, in this study, we used established cellular models of HIV-1 latency, m 6 A-specific sequencing at single-base resolution, and functional assays. We demonstrate that HIV-1 latency reversal leads to increased levels of cellular m 6 A modification, correlates with cellular m 6 A levels, and is dependent on the catalytic activity of the m 6 A methyltransferase enzyme. We also identified cellular genes that are differentially m 6 A-modified during HIV-1 reactivation, as well as the sites of m 6 A within HIV-1 RNA. Our novel findings point toward a significant role for m 6 A modification in HIV-1 latency reversal.

The m6A reader YTHDC2 is essential for escape from KSHV SOX-induced RNA decay

Viral and Cellular N 6 -Methyladenosine and N 6 ,2′- O -Dimethyladenosine Epitranscriptomes in the KSHV Life Cycle

m6A Regulates the Stability of Cellular Transcripts Required for Efficient KSHV Lytic Replication

M6a-Binding Proteins: the Emerging Crucial Performers in Epigenetics

m6A Reader Proteins: The Executive Factors in Modulating Viral Replication and Host Immune Response

Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells

Epitranscriptomic M6a Modification in the Stem Cell Field and Its Effects on Cell Death and Survival.

m6A modification controls the innate immune response to infection by targeting type I interferons

RNA M6a Methylation Regulates Virus–host Interaction and EBNA2 Expression During Epstein–Barr Virus Infection

N6-methyladenosine modification—a key player in viral infection

Regulation of Antiviral Immune Response by N6-Methyladenosine of mRNA

Regulation of Virus Replication and T Cell Homeostasis by N6-Methyladenosine

Regulation of Virus Replication and T Cell Homeostasis by N 6 -Methyladenosine

m6A Methylation in Regulation of Antiviral Innate Immunity

Epitranscriptomic m6A modifications during reactivation of HIV-1 latency in CD4+ T cells

Modifying the antiviral innate immune response by selective writing, erasing, and reading of m6A on viral and cellular RNA

Global profiling reveals common and distinct N6-methyladenosine (m6A) regulation of innate immune responses during bacterial and viral infections

N6-methyladenosine modification enables viral RNA to escape recognition by RNA sensor RIG-I

HIV protease cleaves the antiviral m6A reader protein YTHDF3 in the viral particle

Lactylation of RNA m6A demethylase ALKBH5 promotes innate immune response to DNA herpesviruses and mpox virus.

Integrated analysis of m6A regulator-mediated RNA methylation modification patterns and immune characteristics in Sjögren's syndrome